It will be interesting to see if we get the 10Q to
Post# of 30028
Posted On: 08/23/2016 4:54:00 PM
It will be interesting to see if we get the 10Q today. It's due.
Also, no one is talking about the fact that they haven't changed the toxic financing to a $0.05 conversion price yet.
The 8K said the board approved it, they needed the consent of the toxics, and once they had the consents they would amend the Series E and H certificates of designation in NV.
No filings have been made in NV, so we still have toxic financing at 65% (Series E) and 75% (Series H) of the market price.
Until they change it in NV, it doesn't count.
Also, no one is talking about the fact that they haven't changed the toxic financing to a $0.05 conversion price yet.
The 8K said the board approved it, they needed the consent of the toxics, and once they had the consents they would amend the Series E and H certificates of designation in NV.
No filings have been made in NV, so we still have toxic financing at 65% (Series E) and 75% (Series H) of the market price.
Until they change it in NV, it doesn't count.
(4)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼